Alexander Yanovskiy, DPM
Podiatrist · Des Plaines, ILNPI 1992724488
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,180 of the $5,211 with a category attached, or 61.0%. 17 manufacturers reported payments, led by Stryker at 53.1% of the total.
Across 80 payments — averaging $65.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Paragon 28, Inc.$863
- Treace Medical Concepts, Inc.$519
- Acera Surgical, Inc.$450
- Smith+Nephew$103
- Bioventus LLC$82
- plus $425 from 11 others
What the payments were for
- Travel & lodging$1,48528%
- Food & beverage$3,18061%
- Gifts$972%
- Other$4509%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 38 | $2,769 |
| Paragon 28, Inc. | 6 | $863 |
| Treace Medical Concepts, Inc. | 7 | $519 |
| Acera Surgical, Inc. | 1 | $450 |
| Smith+Nephew | 4 | $103 |
| Bioventus LLC | 4 | $82 |
| Zimmer Biomet | 2 | $73 |
| Paratek Pharmaceuticals, Inc. | 4 | $68 |
| Amgen(2 entities) | 3 | $58 |
| Organogenesis Inc. | 3 | $52 |
| Next Science LLC | 2 | $45 |
| Integra Lifesciences Corporation | 1 | $27 |
| Medwest Associates | 1 | $25 |
| Abbott | 1 | $23 |
| Orthofix Medical, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $18 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRIME SERIES$732
- Product Portfolio$698
- Restrata Wound Matrix$450
- Actishield$239
- CUT GUIDE$216
- Lapiplasty System$146
- EASYFUSE$143
- PROSTEP MICA$128
- CARTIVA$125
- ORTHOLOC 3DI$120
- AUGMENT INJECTABLE$117
- PROPHECY$114
- STAR$109
- VARIAX$109
- T2$109
How this compares
$5,211 in reported general payments places this provider in the 85th percentile of 409 podiatrist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 16 | $169 |
| Allopurinol | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Des Plaines
- David YeagerMorrison$345K
- Paul KirchnerNew Lenox$143K
- William BushRockford$141K
- Daniel BrownHarrisburg$136K
- Syed HusainArlington Heights$82K
- Timothy GrahamTaylorville$70K
- Paul PotachWheeling$45K
- Steven JasonowiczBarrington$34K
- Jaclyn SchumannJoliet$29K
- Zehra HyderiAlgonquin$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.